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ENGLISH SUMMARY 
Nearly 50 million people worldwide have epilepsy and one-third of them do not 
respond well to any antiepileptic drugs. Given the large population of patients 
experiencing drug resistant epilepsy, increased attention has been paid over the last 
two decades to the development of electrical stimulation therapies as alternative 
antiepileptic treatments.  In spite of these developments, the antiepileptic efficacy of 
such electrical stimulation therapies is still relatively low. The efficacy of these 
therapies may be improved by optimizing the stimulation parameters. 
The thesis hypothesized that the antiepileptic effects of vagus nerve stimulation 
(VNS) and spinal cord stimulation (SCS) could be improved by using higher 
stimulation frequencies than currently applied or proposed. To test this hypothesis, 
three studies were conducted using a pentylenetetrazole induced Spike-and-Wave 
(SW) model in rats. 
Study 1 and Study 2 explored the effect of high frequency SCS and VNS (i.e. 
80 Hz, 130 Hz and 180 Hz) in inhibiting SW seizures. For comparison, the 
investigated stimulation frequencies also included the stimulation frequencies 
commonly used in the clinics today, i.e. 30 Hz for SCS, and 10 Hz and 30 Hz for 
VNS. 
In Study 3, the effect of the VNS and SCS frequencies was further analyzed by 
investigating how those frequencies influenced fast ripple activity. Fast ripples are 
250-600 Hz transient oscillations which appear to reflect the pathological process 
related to seizure generation. Fast ripples have previously been used to define the 
seizure onset zone, predict epileptic seizures and estimate the severity of seizures as 
an epileptic biomarker. Study 3, for the first time, evaluated how electrical 
stimulation at different frequencies influences the fast ripples under the seizure 
condition. 
The thesis demonstrated that high frequency VNS and SCS (i.e. 130 Hz and 180 Hz) 
resulted in higher seizure attenuation and higher reduction in fast ripples than what 
was obtained at lower frequencies (10 Hz, 30 Hz and 80 Hz). As such, the results 
suggested that the antiepileptic effect of clinically used VNS and the potential 
antiepileptic therapy SCS may be optimized by using high stimulation frequency. 
Further studies are needed to explore if the effects observed in this study are similar 
in chronic epilepsy models and in patients. 
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DANISH SUMMARY 
Der er ca. 50 millioner mennesker i verden, der lider af epilepsi. 30-40% af disse har 
ikke gavn af antiepileptisk medicin (AED). Der har derfor i de seneste årtier været 
øget en øget fokus på at anvende elektriske stimulation som en alternativ behandling 
for patienter, der lider af svær epilepsi. Virkningen af disse elektriske terapiformer, 
som er stadig relativ beskeden. Den antiepileptiske virkning kan muligvis forbedres 
ved at optimere stimulationsparametrene inklusive stimulationsfrekvensen.  
Hypotesen var, at den antiepileptiske virkning af vagus nerve stimulation (VNS) 
eller rygmarvs stimulation (SCS) kunne forbedres ved at anvende en højere 
stimulationsfrekvens end den, der anvendes i den klinisk praksis i dag og som 
foreslås i litteraturen. For at undersøge hypotesen blev en dyremodel udviklet hvor 
at spike-wave (SW) anfald blev kunstigt induceret via pentylenetetrazol (PTZ).  
Studie 1 og Studie 2 blev udført for at vurdere den antikonvulsive virkning af 
henholdsvis SCS og VNS samt fastlægge hvilken frekvens, der inducerede maksimal 
anfaldsdæmpning. Studie 2 blev udført for at vurdere, om VNS udført med højere 
frekvenser end de, der anvendes i klinisk praksis i dag (dvs. 20-30 Hz), ville være 
mere effektive til anfaldskontrol. Der blev anvendt stimulationsfrekvenser mellem 
10 og 180 Hz, og deres virkning til at hæmme anfald blev sammenlignet 
I Studie 3 blev virkningen af VNS og SCS yderligere analyseret ved at undersøge 
ændringer i den høj-frekvente del af hjerneaktiviteten (refereres til som high 
frequency oscillations – eller HFO) under stimulation.  De højfrekvente svingninger 
ligger i området 250-60 Hz og menes at spille en vigtig rolle i generering og 
udbredelse af anfald. De hurtige bølger er tidligere blevet anvendt som en markør for 
epilepsi, til lokalisering af det anfaldsgivende område, forudsigelse af anfald og 
vurdering af styrken af anfald. Studie 3 undersøgte for første gang, hvordan 
elektrisk stimulation med forskellige frekvenser påvirker de hurtige bølger under 
anfaldstilstand.  
Afhandlingens resultater indikerer  at højfrekvent VNS og SCS (dvs. 130 Hz og 180 
Hz) resulterede i højere dæmpning af anfald og højere reduktion i hurtige 
hjernebølger end hvad der kunne opnås ved at anvende lavere stimulations 
frekvenser (10 Hz, 30 Hz og 80 Hz). Dermed peger resultaterne på, at den 
antiepileptiske virkning af  VNS og SCS kan optimereres ved brug af en højere 
stimuleringsfrekvens end hvad der typisk anvendes i dag. Yderligere forsøg er 
nødvendige for at undersøge, om den virkning, som blev observeret i dette studie, 
svarer til virkningen i modeller for kronisk epilepsi og hos patienter.  
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1. INTRODUCTION 
Epilepsy is one of the most common neurological diseases affecting more than 2 
million people in the United States (Helmers et al. 2015) and more than 3.4 million 
in Europe (Forsgren et al. 2005). The serious impact of epileptic seizures includes 
mental impairment and body trauma and as a consequence shortens the life span of 
the patients. Patients experiencing an onset of epilepsy in their early years of life 
have to tolerate a heavy psychological, physical and financial burden as individuals 
and to their families (Beletsky and Mirsattari 2012). The epileptic seizures can be 
controlled by antiepileptic drugs or epilepsy surgery in 60-70 % of the patients 
(Muñana 2013). However, there are still around 30-40 % patients where the seizure 
control is not effective by applying these traditional therapies. 
Therefore, identifying novel methods to control drug resistant epilepsy is important. 
As a result, electrical stimulation, as an alternative treatment for patients with 
refractory epilepsy, has received increased attention over the last decades (Ben-
Menachem 2012). The efficacy of current electrical therapies is still relatively low 
(De Herdt et al. 2007; Fisher et al. 2010), and therefore, the focus of the present 
thesis was to investigate options to improve the antiepileptic efficacy of the 
electrical stimulation treatments. 
 
1.1. Pathophysiology of epilepsy and seizures 
Epilepsy is manifested as recurrent, unpredictable seizure activity. Seizures are short 
spontaneous episodes, which may involve shaking of a part of or all of the body, 
with or without simultaneous loss of awareness (Jacoby et al. 2005). These episodes 
are caused by excessive, synchronous electrical discharges of brain neurons. Since 
the seizures may start from different regions of the brain, the symptoms of epilepsy 
vary and therefore largely depend on the original location of the seizure focus and 
the propagation of the seizures. Seizures are classified into two categories, i.e. the 
primary generalized seizures and focal seizures. In the first case, synchronous 
discharges are initiated throughout the whole brain, whereas the synchronous 
discharges are confined in a limited brain region in focal seizures (Jacoby et al. 
2005). 
On the basis of their clinical manifestations and the characteristics of the associated 
electroencephalographic (EEG) discharges, the generalized seizures could be further 
classified as absence, myoclonic, clonic, tonic, tonic-clonic (TC) and atonic seizures, 
in which absence and TC seizures, formerly known as petit mal and grand mal 
seizures, are the two main types (Angus-Leppan and Parsons 2008). The absence 
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seizures are typically characterized by an abrupt loss and return of awareness often 
associated with a 2-3 Hz spike-and-wave (SW) activity on EEG, thus also mentioned 
as SW seizures (Angus-Leppan and Parsons 2008). In contrast, the typical TC 
seizure comprises a tonic phase (loss of consciousness and stiffness of body) and a 
clonic phase (rhythmic shaking) associated with a 10-20 Hz SW activity (Mayville 
et al. 2000). The TC seizures may occur independently or evolve from the absence 
seizures (Mayville et al. 2000). 
The underlying cause of different types of seizures is not always clear, which make 
the prevention of epilepsy difficult. In fact, in 60 % of the cases the epilepsy is 
idiopathic which is not preventable. Other cases are classified as secondary epilepsy 
with identifiable causes, such as brain damage from an injury, stroke, brain tumor or 
infection (WHO 2015). 
Independent of their type and cause,  seizures reflect imbalances between inhibitory 
and excitatory neuronal networks in the brain (McCormick and Contreras 2001). 
These imbalances are often associated with a reduction of gamma-aminobutyric 
acid (GABA) inhibition and an enhancement of the N-Methyl-D-aspartate (NMDA) 
receptor-mediated excitation (McCormick and Contreras 2001) and result in an 
abnormal, hypersynchronous neuronal discharges from which the seizure emerges 
(Badawy et al. 2009). Furthermore, the neurons engaged in seizures are 
characterized by sustained firing of action potentials, which is possibly triggered by 
the so-called “paroxysmal depolarization shifts” (Lado and Moshé 2008; Avoli 
2014). The hypersynchronous paroxysmal shifts occurring in a group of cortical 
nearby neurons generate the EEG seizure spikes characteristic for the epileptic brain 
(Bazhenov et al. 2008). 
 
1.2. Electroencephalographic (EEG) biomarkers for epileptic 
seizures 
The diagnosis of epilepsy is commonly made on the basis of observing two 
unprovoked seizures occurring separated by more than 24 hours (Fisher et al. 2014). 
In many cases, it is highly difficult to diagnose epilepsy only based on a patient’s 
self-reported experience without further objective evidence (Goodin and Aminoff 
1984). Since the brain’s bioelectricity can be recorded by the EEG technique, the use 
of EEG recordings has become an important tool in diagnosing epilepsy, classifying 
seizure types and localizing the epileptogenic focus (Crunelli and Leresche 2002; 
Acharya et al. 2013). 
An epileptic EEG biomarker is defined as an objective, reliable measure (or feature) 
extracted from the EEG signal that reflects the typical characteristics of epilepsy, 
such as presence and progression, severity and the location of the seizure focus 
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(Pitkänen and Engel 2014). A reliable EEG epileptic biomarker may facilitate the 
process of predicting which patient will develop epilepsy, which part of the brain is 
responsible for the development of epilepsy (epileptogenesis) and which treatment 
may be the preferred option for an individual seizure control (Staba et al. 2014; 
Pitkänen and Engel 2014).  
One of the most life-threatening characteristics of the epileptic seizures is their 
unpredictable nature (Litt and Echauz 2002). Consequently, the prediction of 
seizures based on advanced use and interpretation of the EEG signals has been the 
vision of many epileptologists in the past (Elger 2001; Lehnertz et al. 2007). Indeed, 
prediction of seizures would not only allow to warn the patients on an upcoming 
seizure, but may also pave the way for closed-loop anti-seizure strategies, such as 
on-demand neuromodulation therapies triggered by real-time EEG seizures 
prediction or early detection (Li and Mogul 2007; Mormann et al. 2007; Feldwisch-
Drentrup et al. 2010). 
Since it is often too late to counteract or prevent a seizure once it has started, the 
ictal EEG recordings are less-than-ideal in terms of searching for epileptic 
biomarkers. Therefore,  more relevant intervals to search for such biomarkers would 
be the interictal intervals (Staba et al. 2014). Indeed, some commonly used 
biomarkers for seizures are currently the EEG interictal spikes, i.e. the abnormal 
EEG spikes occurring between the seizures (Staba et al. 2014). Although these 
interictal spikes have relatively high specificity for the epileptic brain, their role as 
predictors of seizures is still not satisfactory due to the relatively low correlation of 
such spikes and the actual origin, occurrence, and severity of seizures (Worrell and 
Gotman 2011). 
As a result, recent research has moved towards examining interictal high-frequency 
oscillations (HFOs, 100–600 Hz) such as ripples (80–200 Hz) and fast ripples 
(FRs, 250–600 Hz). Ripples occur during normal physiological processes and play 
an important role in learning, memory, and deep sleep (Engel and da Silva 2012).  In 
contrast, the FRs are specifically associated with the epileptogenic brain and seem to 
reflect pathological, hypersynchronous events exclusively (Bragin et al. 1999; 
Urrestarazu et al. 2007; Engel et al. 2009; Bragin et al. 2010). Consequently, the FRs 
have been used to identify seizure foci with higher specificity and sensitivity than 
the traditional interictal EEG spikes (Bragin et al. 1999; Jacobs et al. 2008; Jacobs et 
al. 2010; Akiyama et al. 2011). As a promising epileptic biomarker, it would be 
therefore essential to better understand the value of the FRs in relation to the severity 
of seizures and in response to the antiepileptic therapies. 
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1.3. Pharmacological and surgical treatments of epilepsy 
The primary treatment for seizure control is the administration of anti-epileptic 
drugs (AEDs). The pharmacological treatment of epilepsy started in 1857 and more 
than 24 AEDs are available on the market today (Brodie 2010; Sankaraneni and 
Lachhwani 2015). Generally, AEDs stop seizures by either enhancing the GABA 
inhibitory neurotransmission, or by attenuating the excitatory neurotransmission 
through modulating the activity of the neuronal sodium and/or calcium ion channels 
(Brodie 2010; Brodie and Sills 2011; Sankaraneni and Lachhwani 2015). However, 
the epileptic seizures remain poorly controlled in one-third of the patients with 
epilepsy receiving AEDs (Muñana 2013). In spite of the remarkable progress 
regarding the development of AEDs, these drugs are only effective in relieving the 
epileptic symptoms without reliable evidence of a reversion of the underlying causes 
of epileptogenesis (Sankaraneni and Lachhwani 2015). Furthermore, patients 
receiving AEDs may experience drug-related adverse effects which affects the 
quality of their life, such as cognitive impairments, fatigue, decreased bone density 
and birth defects (Schuele and Lüders 2008).  
 
Figure 1. The current treatment algorithm in epilepsy. 
 
When the AEDs medication fails to work or when the side effects of the AED 
treatments are intolerable, surgical resection of the epileptic focus is preferentially 
considered. However, this intervention is not always possible because removal of the 
epileptic focus can only be performed when the seizure onset region can be well 
defined and when the identified region is accessible (Engel 2003; Fridley et al. 2012; 
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Nowell et al. 2014 Apr 9). In addition, even if these conditions are met, the 
candidates for such procedure still have to undertake the potential risks of 
undergoing surgery and removal of brain functional tissues. Consequently, only 
around 12.5 % patients with refractory epilepsy are suitable for and accept this 
surgical intervention (Van’T Klooster et al. 2011) and only around 8 % of them 
succeed to be seizure free after brain surgery (Mogul and van Drongelen 2014). 
Therefore, a substantial number of epilepsy patients remain intractable by 
conventional therapies and are unable to achieve an effective seizure control. Except 
the dietary therapies, the only alternative options for such patients with intractable 
epilepsy are currently the electrical stimulation therapies for seizure control 
(Muñana 2013) (Fig. 1). 
 
1.4. Electrical stimulation for seizure control 
Electrical stimulation against seizures has attracted increasing attention as an 
alternative therapeutic option for epileptic patients in the last two decades (Zabara 
1992; Mirski et al. 1997; Fanselow et al. 2000; Ozcelik et al. 2007; Fisher et al. 2010; 
Harreby et al. 2011a; Lüttjohann and van Luijtelaar 2013). Electrical stimulation for 
patients with refractory epilepsy has been proposed in a variety of modalities (Mogul 
and van Drongelen 2014), such as vagus nerve stimulation (VNS), deep brain 
stimulation (DBS) and spinal cord stimulation (SCS). Today, VNS and DBS are 
approved for clinical application and achieve around 50 % of reduction of seizures 
in around 50 % of the implanted patients (De Herdt et al. 2007; Fisher et al. 2010) 
whereas SCS for epilepsy was only recently tested in animal studies exclusively 
(Ozcelik et al. 2007; Harreby et al. 2011a; Jiao et al. 2013). 
A core principle of the electrical stimulation therapies for epilepsy is to supply this 
treatment through minimally invasive procedures with maximum efficacy and 
minimum adverse effects. However, because the antiepileptic effect of the electrical 
stimulation therapies depends on many aspects, such as the stimulation target and 
parameters (including the pulse frequency, intensity and duration), and on the types 
of seizures, the reported outcomes of studies considering such issues have been 
inconsistent so far (Mogul and van Drongelen 2014). Moreover, such therapies may 
activate different neural pathways (Mirski and Fisher 1994; Koo 2001; Henry 2002; 
Schlaier et al. 2007) and therefore it is important to understand the mechanisms 
through which those therapies may inhibit seizures and what the proper stimulation 
paradigms may be for this purpose. This is discussed in the following subsections.  
1.4.1. Vagus nerve stimulation (VNS) 
VNS was the first attempt to use electrical stimulation to attenuate seizures and is 
currently the most used adjunctive treatment for refractory epilepsy. The VNS 
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system consists of a helical stimulation electrode, which is surgically placed around 
the left cervical vagus nerve, and a stimulator implanted under the skin in the upper 
chest region. The stimulator sends stimulation pulses intermittently to the vagus 
nerve through leads connected subcutaneously with the electrode (Cyberonics 2014). 
VNS was approved for the treatment of intractable epilepsy in Europe in 1994 and in 
the U.S. in 1997 (Fridley et al. 2012; Granbichler et al. 2015 Jan 12). By 2013, there 
were more than 60 000 patients with refractory epilepsy who have been implanted 
with a VNS device for seizure control (Granbichler et al. 2015). Besides the 
antiepileptic application, the VNS has been recently approved as a therapy for 
depression, which gives an additional advantage for using VNS for seizure control 
as the prevalence of depression in epileptic patients is almost 10 times higher than in 
the non-epileptic population (Schuele and Lüders 2008). 
The anticonvulsive mechanisms of VNS are still unclear and presumably both 
peripheral and central neural networks may be involved. With regard to the 
peripheral effects, different types of vagal fibers may be involved in the 
anticonvulsive effect of VNS (Krahl 2011). An early study showed that recruitment 
of small unmyelinated C-fibers of the vagus nerve was required for inducing an 
antiepileptic effect through VNS (Woodbury and Woodbury 1990). However, more 
recent studies have shown that activation of the large myelinated A and B fibers 
through VNS is sufficient for the attenuation of seizures (Banzett et al. 1999; Krahl 
et al. 2001; Krahl 2011). With regard to the central effects of VNS, the brain areas 
which may be influenced through projections from the vagus nerve nucleus of the 
solitary tract are widespread (Schachter 2006). Among these brain structures, the 
thalamus plays an important role in seizure suppression through VNS (Fig. 2) 
(Garnett et al. 1992; Henry et al. 1998; Henry et al. 1999; Ring et al. 2000; Ben-
Menachem 2002; Barnes et al. 2003; Ito and Craig 2005). 
The typically used stimulation frequency in the VNS therapy is 20-30 Hz (Ben-
Menachem 2002) and very few studies have been conducted to evaluate the 
antiepileptic effects of other VNS frequencies. Zabara initially reported that VNS at 
a frequency of 80-150 Hz attenuated seizures in dogs (Zabara 1985; Zabara 1987). 
Woodbury et al. found, however, that the effective VNS frequency range was 
approximately 10-20 Hz in rats (Woodbury and Woodbury 1990). In a later study, 
Zabara reported that VNS attenuated seizures when stimulating in the frequency 
range of 20-150 Hz, where the highest effect was found in the frequency range of 
30-60 Hz (Zabara 1992). Directly based on these later Zabara’s results, 30 Hz was 
chosen as an antiepileptic frequency in the majority of patients receiving the VNS 
treatment (Krahl 2011). However, the evidence that this VNS frequency is optimal is 
still limited since the Zabara’s study was conducted without a statistical analysis 
(Zabara 1992). Therefore, it is important to further evaluate the possibility of 
optimizing VNS frequency. 
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1.4.2. Deep brain stimulation (DBS) 
DBS was the second neuromodulation technique that was approved for seizure 
control in Europe in 2010 and in the U.S. in 2013. DBS implies the implantation of a 
pacemaker subcutaneously in the upper chest region, which sends electrical pulses to 
electrodes placed in specific areas of the brain, such as the thalamus and 
hippocampus (Laxpati et al. 2014). 
DBS has been successfully applied on different neurological disabilities of the 
central nervous system, including motor disorders such as dystonia, Parkinson’s 
disease and essential tremor, and some neuropsychiatric disorders, such as the 
Tourette’s syndrome, obsessive-compulsive disorder, depression and epilepsy (Yu 
and Neimat 2008; Hariz et al. 2010; Sironi 2011; Dzirasa and Lisanby 2012; House 
2012; Blomstedt et al. 2013; Laxpati et al. 2014; Segar et al. 2015). While the 
mechanisms of DBS are still unclear, it has been demonstrated that the influence of 
DBS was not limited to affecting the brain exclusively, but also the peripheral 
nervous system (Dzirasa and Lisanby 2012). In addition, the effect of DBS seems 
largely dependent on the stimulation target and the stimulation frequency (Fitzgerald 
and Segrave 2015). 
With respect to the stimulation target, the thalamus was often suggested as a suitable 
antiepileptic DBS target (Lado et al. 2003; Takebayashi et al. 2007; Fisher et al. 
2010; Fisher and Velasco 2014). Regarding the DBS frequency, studies have shown 
that DBS applied at a frequency above 100 Hz had an inhibitory effect on the 
neuronal discharges and hence the seizures, whereas 50-60 Hz oppositely tended to 
have an excitatory effect (Benabid 2003). The suggested DBS frequency for seizure 
control was therefore around 130 Hz, with an effect of around 50 % of seizure 
reduction in about 50 % of the implanted patients (Fisher et al. 2010; Laxpati et al. 
2014). 
Compared with VNS, DBS is more invasive and requires complicated intracranial 
implantation procedures and advanced techniques to localize the target structures in 
brain  (Fuentes et al. 2009).  Due to potentially serious side-effects related to those 
issues and without clear evidence of antiepileptic effects superior to those induced 
by VNS, and to the fact that the stimulation parameters of DBS have been 
thoroughly evaluated in previous studies (Fisher 2013; Fisher and Velasco 2014), 
DBS was not investigated in this Ph.D. work. 
1.4.3. Spinal cord stimulation (SCS) 
SCS has been used for relieving pain since 1967 (Shealy et al. 1967) and has become 
a routine treatment for neuropathic pain today (Wolter 2014). For patients receiving 
SCS, an SCS stimulator is implanted subcutaneously on the abdomen or buttocks 
and the stimulation pulses are transmitted to the spinal cord through a wire electrode 
placed in the epidural space. 
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Given the abundance of sensory fibers ascending through the dorsal column pathway, 
SCS is currently considered as a much under-utilized therapeutic option (Foreman 
and Linderoth 2012). Besides pain relief, an increasing number of studies have 
shown that SCS may also have a positive effect on neurological, peripheral vascular, 
motor, gastrointestinal and cardiac diseases (Ozcelik et al. 2007; Fuentes et al. 2009; 
Harreby et al. 2011a; Fénelon et al. 2012; Foreman and Linderoth 2012). 
From a mechanistic perspective, recent studies suggested that SCS may inhibit the 
cortical excitability (Schlaier et al. 2007). As epileptogenesis is clearly linked to an 
increased cortical excitability (Danober et al. 1998; Duncan et al. 2006; Bazhenov et 
al. 2008), SCS may counteract this cortical condition and thus become an 
antiepileptic therapy. As already mentioned, high frequency thalamic stimulation 
attenuates seizures (Lado et al. 2003; Takebayashi et al. 2007; Fisher et al. 2010) 
and therefore indirect stimulation of the thalamus through SCS may have similar 
effects ( Cox et al. 1997; Jiao et al. 2013) (Fig. 2).  
 
 
Figure 2. Potential key pathways for stimulation-induced attenuation of seizures. 
 
Until now, the studies designed for exploring the possible antiepileptic effects of 
SCS have been very limited (Ozcelik et al. 2007; Harreby et al. 2011a). Thus, 
Ozcelik et al. reported that SCS conducted at 4 Hz inhibited interictal discharges in 
rats (Ozcelik et al. 2007). Harreby et al. found that SCS tended to attenuate seizures 
at higher stimulation frequencies (Harreby et al. 2011a). Added to the above 
discussed theoretical considerations, these experimental results of Ozcelik et al. and 
Harreby et al. indicate that SCS may be a future application for seizure control. In 
fact, SCS conducted at a frequency above 100 Hz has previously been reported to 
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completely prevent seizures in two patients with concomitant epilepsy while 
receiving this SCS treatment for spasticity (Waltz et al. 1981). Thus, one of those 
patients had a history of 3-4 seizures weekly for six years and became totally seizure 
free for 18 months since undergoing SCS. The other patient had suffered from 8-10 
absence seizures and 1-2 tonic-clonic seizures per day and this patient experienced 
no seizures for eight months after starting to use SCS. Although the study of Waltz 
et al. was not designed for examining the effect of SCS on epileptic patients (Waltz 
et al. 1981), the antiepileptic effects of high frequency SCS reported by this author 
deserves further attention. 
1.4.4. The influence of electrical stimulation on fast ripples (FRs) 
High frequency oscillations (HFOs) in the frequency range of 100–600 Hz are 
cortical field potentials that reflect transient synchronization of neuronal electrical 
activity. HFOs can be recorded from hippocampus, parahippocampal structures and 
neocortex of humans and animals (Buzsáki et al. 1992; Bragin, Mody, et al. 2002; 
Engel et al. 2009; Telenczuk et al. 2011). Until present, two types of HFOs have 
been characterized based on their frequency range, i.e. ripples in the frequency range 
of 80–200 Hz and fast ripples (FRs) in the frequency range of 250-600 Hz (Bragin et 
al. 1999; Bragin et al. 2004; Engel et al. 2009; Engel and da Silva 2012). 
As already mentioned, ripples are associated with normal physiological processes 
reflecting summed postsynaptic potentials which play an important role in memory, 
learning and deep sleep (Buzsáki et al. 1992; Ylinen et al. 1995; Engel and da Silva 
2012). In contrast to ripples, FRs have been exclusively observed in epileptogenic 
regions in both epileptic animal models and patients, and are considered to reflect 
pathological, hypersynchronous events related to bursting pyramidal cells (Bragin et 
al. 1999; Engel et al. 2009; Bragin et al. 2010). 
Concerning the consistent association with seizures, FRs are believed not only to 
facilitate the understanding of fundamental neuronal mechanisms of epileptogenesis, 
but also to have a direct clinical value (Bragin et al. 1999). As such, the FRs have 
been used to identify seizure onset zones with higher sensitivity and specificity than 
the traditional EEG interictal spikes (Bragin et al. 1999; Jacobs et al. 2008; Van’T 
Klooster et al. 2011). In addition, resection of FRs-producing tissues has led to better 
results than removing spike-generating brain tissues in patients subjected to surgical 
resection of the seizure foci (Jacobs et al. 2010; Akiyama et al. 2011). Moreover, rat 
studies have shown that FRs are associated with both how often the seizures occur 
and with the severity of seizures (Bragin et al. 2004; Bechstein et al. 2012). This was 
also observed in human studies, where the amount of HFOs increased linearly with a 
reduction of AEDs administration (Zijlmans et al. 2009) and higher HFO rates were 
found in the patients experiencing more seizures (Kerber et al. 2013). 
Although the mechanisms of neuromodulation to inhibit seizures are not well 
understood, it is likely that electrical stimulation targeting different brain regions 
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leads to desynchronization of the ictal hypersynchronized activity (Mirski and Fisher 
1994; Koo 2001; Henry 2002). Since the FRs are considered as a phenomenon 
reflecting hypersynchronized action potentials (Bragin et al. 2010), the antiepileptic 
effects of the electrical stimulation therapies may therefore be associated with their 
ability to modulate the FR activity. Indeed, a recent study in humans showed that the 
FRs were attenuated globally as an effect of 50 Hz brain stimulation using subdural 
electrodes (Jacobs et al. 2014). However, it is still unknown if and how different 
stimulation parameters may influence the FRs and answering such questions may 
have important implications for understanding the mechanisms of both antiepileptic 
neuromodulation therapies and the FRs themselves. 
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2. OVERVIEW OF THE PH.D. WORK 
2.1. Hypothesis  
Given the large population of patients experiencing drug resistant epilepsy, 
increased attention has been paid the over last two decades to the development of 
electrical stimulation therapies as alternative antiepileptic treatments. In spite of 
these developments, the antiepileptic efficacy of such electrical stimulation therapies 
is still relatively low, i.e. 50 % reduction of seizures in 50 % of the implanted 
patients (Mogul and van Drongelen 2014). One reason for not being able until now 
to increase this efficacy could be the limited knowledge about the effect of the 
stimulation parameters regarding their ability to inhibit seizures. Therefore, one 
possible way to improve the efficacy of either established or potential antiepileptic 
therapies, such as VNS and SCS, respectively, is to optimize the stimulation 
parameters used in these methods. 
A previous study in rats has suggested that higher frequency (> 54 Hz) SCS may 
reduce the seizure susceptibility (Harreby et al. 2011a). Besides the evidence from 
this animal study, an early human study also reported that two patients with 
secondary epilepsy became seizure free while receiving SCS at a frequency of 
100 Hz (Waltz et al. 1981). Similarly, a recent VNS study in rats suggested that the 
antiepileptic effect of this therapy might be improved by using a stimulation 
frequency of 100 Hz (Alexander and McNamara 2012). These studies indicate that 
high SCS and VNS frequencies might be important for seizure control. 
The hypothesis of the thesis was that the antiepileptic effects of VNS and SCS 
can be improved by using stimulation frequencies higher than the VNS and 
SCS frequencies currently applied or proposed. 
 
2.2. Experimental studies 
To address this hypothesis, three experimental studies were designed in this Ph.D. 
project. 
Study 1 and Study 2 explored the effect of high frequency (i.e. 80 Hz, 130 Hz and 
180 Hz) SCS and VNS in inhibiting spike-and-wave (SW) seizures. For comparison 
reasons, the investigated stimulation frequencies also included the stimulation 
frequencies commonly used in the clinics today, i.e. 30 Hz for SCS, and 10 Hz and 
30 Hz for VNS (Ben-Menachem 2012; Jiao et al. 2013). 
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Since the FRs seem to reflect the neuronal hyperexcitability and hypersynchrony 
leading to seizures (Bragin, Wilson, et al. 2002; Bragin et al. 2010), the effect of the 
VNS and SCS frequencies tested in Studies 1 and 2 on FRs was analyzed in Study 3 
to investigate how those frequencies influenced such neuronal conditions.  
 
2.3. Experimental methodology 
2.3.1. Animal preparation 
Twenty male Sprague-Dawley rats were included in this work, i.e. 9 rats in the SCS 
study, 11 rats in the VNS study, and all 20 rats were included in the FRs analysis 
study. Besides those animals, a number of rats have also been used in preliminary 
studies to develop a stable model of SW seizures, design and test the SCS and VNS 
electrodes and establish the stimulation procedures. The rats were anesthetized using 
a mixture of Ketamine/Xylazine throughout the experiment. In the SCS study, a 
custom made tripolar epidural electrode was placed at the C4-C7 level (Fig. 3A). In 
the VNS study, a custom made bipolar cuff electrode was placed on the left cervical 
vagus nerve (Fig. 3B). The animals were fixed in a prone position in a stereotaxic 
frame. The surface and intracortical brain signals from the right primary 
somatosensory cortex were recorded using a pair of concentric electrocorticographic 
(ECoG) and intracortical (IC) electrodes (Fig. 3C). 
2.3.2. Seizure induction 
A pentylenetetrazole (PTZ) induced SW seizure model was developed and used for 
evaluating the anticonvulsive effects of SCS and VNS. The SW seizures were 
induced and maintained stable during the experiments by a two-stage infusion of 
PTZ in the femoral vein. In the first infusion stage, a PTZ infusion rate of 10 
mg/kg/min for two and a half minutes was used to induce 2-3 Hz SW discharges. In 
the second stage, the induced SW seizure activity was maintained stable for two 
hours by a steady PTZ infusion rate of 0.21 mg/kg/min throughout this time interval 
(Fig. 4A). 
2.3.3. Stimulation paradigms 
The stimulation intensity of SCS and VNS was selected as the maximum current 
which did not cause any observable twitch of the cervical muscle during SCS or no 
significant change of heart rate during VNS. The stimulation pulse was charge 
balanced (100 µs negative and 500 µs positive phase). 
The stimulation frequencies of 30 Hz, 80 Hz, 130 Hz and 180 Hz for SCS (Fig. 4B) 
and 10 Hz, 30 Hz, 80 Hz, 130 Hz and 180 Hz for VNS were applied in four 
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consecutive stimulation loops in each animal (Fig. 4C). In one stimulation loop, the 
SCS or VNS pulses were randomly applied with a duration of one minute at each of 
the above specified frequencies. In addition, a control (no stimulation) interval was 
included in each stimulation loop. The stimulation and control intervals were 
separated by a period of five minutes without stimulation in the SCS study and four 
minutes in the VNS study. Four consecutive stimulation loops were applied in each 
rat in both the SCS and VNS study. 
 
Figure 3. Illustation of experimental setup. The SCS electrode was placed at the C4-C7 level 
(A) and the VNS electrode was placed on the left cervical vagus nerve (B). The 
electrocorticographic (ECoG) and intracortical (IC) field potentials were recorded from the 
right somatosensory hindlimb area (C). 
 
2.3.4. Data analysis 
Since the SW activity occurred synchronously in the ECoG and IC recordings and it 
was more clearly defined in the latter, the quantitative analysis was based on the IC 
signal, whereas the ECoG signal was only used for qualitative assessment. To 
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evaluate the frequency-dependent antiepileptic effects of SCS and VNS, traditional 
EEG-based analysis techniques, such as the frequency and power analysis of the SW 
spikes and SW discharges, were used in Study 1 and 2. To assess how the SCS and 
VNS influenced the FR activity, the change of the FR rate derived from the SW 
activity was analyzed in Study 3. 
 
 
Figure 4. The experimental protocol. (A) The SW seizure was induced by 2.5 min PTZ 
infusion (first stage) and maintained for 2 h (second stage). An example of the corresponding 
ECoG and IC recordings during these two phases is shown below the time axis. (B & C) The 
effect of SCS or VNS on the SW activity was evaluated during the second PTZ infusion stage. 
The investigated SCS and VNS frequencies and the control interval were randomly applied in 
one stimulation loop. Four consecutive stimulation loops were performed in each rat.  
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3. SUMMARY OF MAIN FINDINGS 
The present thesis investigated the effects of several SCS and VNS frequencies on 
the SW seizures and on the SW-related FRs. The overall results demonstrated that 
stimulation at high frequency, such as 130 Hz and 180 Hz achieved the highest SW 
attenuation and FR activity reduction for both SCS and VNS. An overview of the 
objectives, results and conclusions of the three studies is summarized in Table 1. 
 
Table 1.  An overview of the three studies conducted in this Ph.D. project. 
 Objective Results & Conclusions 
Study 1 To investigate the effects 
of SCS at frequencies of 
30 Hz, 80 Hz, 130 Hz and 
180 Hz on PTZ induced 
SW seizures. 
1. 30 Hz SCS increased the level of the SW spiking activity, 
which indicated a proconvulsive effect of this SCS 
frequency. 
2. 130 Hz and 180 Hz SCS attenuated the SW spiking 
activity, which suggested an antiepileptic effect of these 
SCS frequencies. 
 
Study 2 To explore the 
effectiveness of VNS at 
frequencies of 10 Hz, 
30 Hz, 80 Hz, 130 Hz and 
180 Hz in inhibiting SW 
seizures. 
 
1. VNS attenuated the SW activity at all investigated 
frequencies. 
2. 130 Hz and 180 Hz VNS induced a 50 % larger 
attenuation of the SW activity than the attenuation achieved 
by 30 Hz VNS. 
3. A VNS frequency in the range of 130 Hz - 180 Hz may 
be more effective in treating refractory epilepsy than 30 Hz 
VNS which is commonly applied in the clinic today. 
 
Study 3 To examine the effect of 
the SCS and VNS 
frequencies investigated in 
Study 1 and 2 on the FRs 
associated with the SW 
seizures. 
1. The FR activity increased in correlation with the increase 
of the PTZ dose and the severity of the SW discharges, 
which confirmed the involvement of FRs in the 
development of SW seizures. 
2. SCS conducted at 80 Hz, 130 Hz and 180 Hz and VNS 
conducted at 30 Hz, 80 Hz, 130 Hz and 180 Hz significantly 
reduced the FR activity, in which stimulation at higher 
frequency resulted in a higher amount of FR reduction.  
3. The results indicate that SCS and VNS may have similar 
supporting mechanisms in attenuating epileptic seizures and 
that the higher frequency SCS and VNS may be more 
effective for seizure control. 
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3.1. The SCS-induced changes of the SW spikes and FRs  
Study 1 quantified the changes induced by SCS on the SW seizures. SCS conducted 
at 130 Hz and 180 Hz attenuated the SW spikes power by 30 % and 32 % and 
reduced the SW spikes frequency by 24 % and 30 %, respectively. Those results 
suggested an anticonvulsive effect of 130 Hz and 180 Hz SCS, whereas SCS at 30 
Hz induced opposite effects and may therefore be proconvulsive.  
Study 3 revealed that SCS conducted at 80 Hz, 130 Hz and 180 Hz significantly 
reduced the FRs rate by 24 %, 38 % and 44 %, respectively. The results suggested 
that the maximum attenuation of the FR activity occurred when stimulating at 
frequencies above 100 Hz. In addition to Study 1, these findings further indicated 
that high frequency SCS could be a potential treatment for intractable epilepsy by 
reducing the neuronal hyperexcitability and hypersynchrony reflected by FRs and 
responsible for the development of seizures. 
 
3.2. The VNS-induced changes of the SW discharges and FRs  
Study 2 estimated the change of the SW power and frequency during VNS. VNS 
performed at 30 Hz reduced the SW power by 14 %. The study also found that VNS 
performed at 130 Hz and 180 Hz induced a 50 % larger attenuation of the SW power 
than what was achieved at 30 Hz. In contrast with effects on the SW power, 30 Hz 
VNS did not induce any change of the SW frequency, whereas VNS induced a 
significant reduction of the SW frequency when conducted at 80 Hz, 130 Hz and 
180 Hz. 
In Study 3, the effects of the VNS frequencies tested in Study 2 on the SW-related 
FRs were analyzed and compared. VNS conducted at 30 Hz, 80 Hz, 130 Hz and 
180 Hz significantly reduced the FRs rate by 23 %, 40 %, 61 % and 65 %, 
respectively, in comparison with the control intervals. The results suggested that the 
larger attenuation of the FR activity occurred when stimulating at frequencies above 
100 Hz. Corroborated with the effects of SCS on the FR activity, the results indicate 
that VNS and SCS have similar effects in attenuating the cortical hyperexcitability 
and hypersynchrony resulting in seizures. In addition, the present results indicate 
that high frequency VNS may be more effective than the currently applied 30 Hz 
VNS in alleviating this cortical condition and thus in inhibiting seizures. 
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4. DISCUSSION 
This thesis investigated the effects of the SCS and VNS frequency on SW seizures 
and on the related FR activity. The main findings are discussed in the following, 
whereas a detailed discussion of the individual studies is available in the 
corresponding papers. 
 
4.1. Methodological considerations 
4.1.1. The PTZ induced SW seizure model 
Animal models of PTZ-induced epileptic seizures are widely used and play an 
important role in developing new antiepileptic therapies and in exploring the 
underlying mechanisms of epileptogenesis (Velisek et al. 1992; Davoudi et al. 2013). 
The typical use of PTZ is for inducing behavioral tonic-clonic (TC) seizures 
(Lüttjohann et al. 2009; Harreby et al. 2011a; Harreby et al. 2011b; Harreby et al. 
2011c), while the SW activity as an indicative of absence seizures is an inevitable 
transitory stage towards TC seizures (Harreby et al. 2011a; Harreby et al. 2011b; 
Harreby et al. 2011c). Unlike the TC seizure stage which is transient, the SW 
seizures can be maintained at a relatively stable level by controlling the blood PTZ 
concentration (Gallitto et al. 1987; Sierra-Paredes et al. 1989). 
In the first step of the study, a stable SW seizures model was developed. The SW 
model was achieved by a combination of a fast PTZ infusion rate for inducing SW 
seizures and a slow PTZ infusion rate for maintaining the SW discharges stable for 
as long as necessary for investigating the tested stimulation frequencies. This 
allowed us to test all the investigated stimulation frequencies four times in a row in 
one and same animal under similar seizure conditions, which is an advantage with 
regard to both the number of data collected per animal and the consistency of the 
induced effects. 
It is known that the different types of generalized seizures (i.e. the SW and TC 
seizures) can occur independently or consecutively. For example, the TC seizures as 
a more serious neurological condition often evolve from the absence SW seizures 
(Mayville et al. 2000). Therefore, compared with the TC models of seizures, the SW 
seizures induced in this study can be considered as modelling lower severity absence 
seizures, which are rarely examined. In fact, the anticonvulsive effects of 30 Hz 
VNS observed in this thesis seem comparable with those induced in epilepsy 
patients by the clinical 30 Hz VNS therapy, which may support the validity of this 
SW model for drug or electrical therapies screening purposes. 
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4.1.2. The selection of the SCS and VNS frequency 
The thesis assessed the antiepileptic effects of SCS conducted at 30 Hz, 80 Hz, 
130 Hz and 180 Hz and VNS conducted at 10 Hz, 30 Hz, 80 Hz, 130 Hz and 180 Hz. 
The rationale to test those frequencies was that 30 Hz is the common VNS frequency 
used in the clinical treatment of epilepsy patients and also close to the typical SCS 
frequency used for pain relief (Ben-Menachem 2002; Song et al. 2014). Meanwhile, 
the higher frequencies of 80-180 Hz assessed in this thesis are typically used in DBS 
for seizure control (DeGiorgio et al. 2006; Schachter 2006; Fisher and Velasco 
2014). The frequency of 10 Hz was chosen as an extra stimulation parameter to be 
tested in the VNS study as it is usually applied to initiate the VNS therapy in patients 
(Cyberonics 2014). Thus, by testing the above mentioned frequencies, the present 
thesis aimed to investigate and compare the antiepileptic effects of the stimulation 
frequencies presently used in clinical VNS and SCS with the effects induced using 
stimulation frequencies proven to be effective with direct stimulation of thalamic 
structures. 
4.1.3. SW spike vs. SW analysis 
In the present thesis, the antiepileptic effects of SCS were quantified based on 
analyzing the SW spikes, whereas those of VNS were quantified based on analyzing 
the SW discharge as a whole. The choice was based on the characteristics of the SW 
changes caused by SCS, which primarily affected the spike component of the SW 
discharges while leaving their wave component almost unchanged. Meanwhile, the 
SW changes induced by VNS appeared to be more complex and therefore required 
the analysis of the entire SW complex as a whole. Due to the different features 
selected for evaluation, it became difficult to compare the efficacy of SCS and VNS 
directly. However, such a comparison has been made using the FR activity, which 
was analyzed in the same way for both stimulation methods in Study 3. 
Since actually the combination of the SW “spikes” and “waves” is an indicative of 
clinical absence seizures (Danober et al. 1998), analyzing only the SW spike 
component with regard to demonstrating an antiepileptic effect of SCS may be 
disputable. However, studies have shown that the spike components of the seizure 
discharges are generated by the paroxysmal depolarizing shifts triggering seizures 
and inhibiting such depolarizing shifts is actually the mechanism of action of several 
common antiepileptic drugs (Stafstrom 2007; Bazhenov et al. 2008; Lado and 
Moshé 2008; Schulze-Bonhage 2010; Muñana 2013; Zaccara et al. 2015). Therefore, 
the outcome regarding the SCS-induced reduction of the SW spikes may indicate a 
potential antiepileptic effect of this procedure, too. 
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4.2. SCS and the suppression of seizures 
Although SCS has been widely used for pain treatment for decades, few studies have 
investigated or reported antiepileptic effects of this therapy, which seems intriguing 
considering the large number of patients implanted with SCS. However, the reason 
for the lack of such reports could be that the commonly used SCS frequency is 
around 40-50 Hz which may be not sufficient to induce an observable seizure 
reduction (Harreby et al. 2011a). In contrast, an anecdotal observation with regard to 
this issue was published by Waltz et al., who reported that 100 Hz SCS prevented 
seizures completely in two patients with epilepsy while being treated for spasticity 
(Waltz et al. 1981). In addition, recent studies also suggested that SCS at a higher 
frequency than that commonly used in the clinics was more effective in relieving 
visceral nociception (Tang et al. 2014) and in facilitating vasodilation (Gao et al. 
2010). 
In Study 1, SCS conducted at 130 Hz and 180 Hz attenuated the SW spikes power 
and frequency by around 30 % and hence had an anticonvulsive effect, whereas SCS 
at 30 Hz induced opposite effects and may therefore be proconvulsive. The 
outcomes of the SCS study are in line with the results of thalamic DBS for seizure 
control both in rats (Mirski and Fisher 1994; Mirski et al. 1997; Vercueil et al. 1998; 
Takebayashi et al. 2007) and in humans (Kerrigan et al. 2004; Fisher et al. 2010). 
For example, studies in rats have shown that 100 Hz and 130 Hz thalamic DBS 
decreased the seizure frequency (Takebayashi et al. 2007) and raised the seizure 
threshold (Mirski and Fisher 1994; Mirski et al. 1997), whereas thalamic stimulation 
at frequency below 10 Hz was proconvulsive (Mirski and Fisher 1994; Mirski et al. 
1997). Similar with the DBS studies, proconvulsive effects of low frequency SCS 
were also observed in a previous study which indicated that 4 Hz SCS increased the 
seizure susceptibility (Harreby et al. 2011a). The similarities of the thalamic DBS 
and SCS regarding their anticonvulsive and proconvulsive effects suggest a similar 
mechanism of action of the two methods. Indeed, the similar effects of thalamic 
DBS and SCS are not unexpected since SCS is actually an indirect way to activate 
thalamic nuclei which are end station for sensory pathways conducted through the 
dorsal columns of the spinal cord (Gildenberg and Murthy 1980; Schlaier et al. 
2007). However, compared with SCS, DBS is a more invasive neuromodulation 
modality and it is also very demanding regarding the techniques to localize the 
seizure foci (Fuentes et al. 2009). In contrast, the SCS electrode can be placed using 
an epidural needle without the surgical exposure of the epidural space and the 
patients can go home the same day after the electrode placement (Linderoth and 
Meyerson 2009). This simple implant procedure allows a preliminary evaluation of 
SCS in epilepsy patients using an external stimulator and transcutaneous electrodes 
before the implantation of permanent SCS system (North et al. 2007; Kunnumpurath 
et al. 2009). Obviously, a preliminary evaluation of this kind is not possible with 
DBS, which is another advantage of SCS as a potential antiepileptic therapy. 
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The antiepileptic mechanisms triggered by SCS are unclear as a definitive 
conclusion in regard to this issue cannot be subtracted from the present work and no 
other similar studies have been performed to date. However, as presented in the 
introductory paragraph of this thesis, the SW spikes appear to reflect the paroxysmal 
depolarizing shifts (Stafstrom 2005; Bazhenov et al. 2008) triggered by 
hyperexcitable and hypersynchronous cortical neurons (Danober et al. 1998; Duncan 
et al. 2006; Bazhenov et al. 2008). The inhibition of the SW spikes by high 
frequency SCS may thus indicate an inhibition of such paroxysmal shifts thereby 
modulating this cortical activity and alleviating the cortical seizures. This possible 
mechanism supporting the effects of high frequency SCS is consistent with the 
results of Study 3 showing an inhibition of the FR activity which is discussed in a 
following paragraph of this section. All in all, the results of the SCS study indicate 
that high frequency SCS could become a new antiepileptic therapy. 
 
4.3. VNS and the suppression of seizures 
VNS has been used as a therapy for patients with refractory epilepsy for more than 
two decades (De Herdt et al. 2007). The currently used 30 Hz VNS frequency is still 
based on an early report by Zabara, who showed the effectiveness of this stimulation 
frequency, but without the support of a statistical analysis (Zabara 1992). Few 
studies have since been conducted to evaluate the antiepileptic effects of other VNS 
frequencies. The results of the present study showed that VNS at 130 Hz and 180 Hz 
achieved a 50% larger attenuation of the SW power compared to the clinically 
recommended 30 Hz VNS, which indicates that 130 to 180 Hz VNS may have a 
stronger antiepileptic effect than the currently used 30 Hz VNS. 
Several antiepileptic effects of high frequency VNS have been previously reported 
in a number of animal studies. In a pioneering research on VNS for seizure control, 
Zabara showed that VNS at a frequency of 80 - 150 Hz inhibited epileptic seizures 
in a dog PTZ model (Zabara 1985; Zabara 1987). Lockard et al. demonstrated that 
50 to 250 Hz VNS attenuated alumina gel induced seizures in monkeys (Lockard et 
al. 1990). Alexander et al. reported that 100 Hz VNS increased the threshold for 
seizures in a rat kindling model (Alexander and McNamara 2012). As in a later 
study Zabara reported that 30 to 60 Hz VNS achieved a higher attenuation of 
seizures than 60 to 150 Hz VNS (Zabara 1992), 30 Hz was chosen as the typical 
frequency for the antiepileptic VNS therapy (Krahl 2011). 
Apparently, the results of the present thesis are in contradiction with the above 
mentioned Zabara’s results (Zabara 1992). One explanation for this contradiction 
could be the difference between the seizure models used by Zabara (i.e. either PTZ 
induced tremors or strychnine induced motor seizures in dogs) (Zabara 1992) and 
the rat model of SW seizures used in this study. In addition, as already stated, a 
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statistical analysis was missing from Zabara’s work (Zabara 1992), which can make 
of the present study a restart for a more rigorous evaluation of the optimal VNS 
frequency for seizure control.  
In contrast to SCS as a possible new method for seizure control, the antiepileptic 
mechanisms of VNS have been investigated in numerous studies. However, the 
mechanistic aspects of VNS, and especially those causing a difference between low 
and high stimulation frequencies, remain unclear. The brain areas influenced by 
projections from the vagal nucleus of the solitary tract are widespread (Schachter 
2006). Among these brain structures, the thalamus seems to play a key role in the 
VNS-modulated seizure suppression (Garnett et al. 1992; Henry et al. 1998; Henry 
et al. 1999; Ring et al. 2000; Ben-Menachem 2002; Barnes et al. 2003; Ito and Craig 
2005). Similar to thalamic DBS for epilepsy (Takebayashi et al. 2007; Fisher and 
Velasco 2014), high frequency VNS may therefore lead to a more effective 
desynchronization of the ictal hypersynchronized cortical activity and thereby to a 
stronger attenuation of seizures. As discussed in the following paragraph, this 
hypothesis seems to be supported by the effects of VNS on the FR activity, which 
was reduced proportional with the VNS frequency.   
 
4.4. The influence of SCS and VNS on the FR activity 
In this thesis, the analysis of the effects of SCS and VNS on the SW discharges was 
followed by an investigation of FR activity during the development of seizures and 
during SCS and VNS. The rationale of this investigation was that the FR activity 
seems to reflect intimate mechanisms related to seizures and understanding how the 
SCS and VNS frequency may interfere with such mechanisms is important in 
improving such methods. Thus, studies have shown that the FR activity reflects 
hypersynchronized discharges of groups of principal cells in the epileptic brain 
where each single FR oscillation is a result of co-firing of a number of close neurons 
(Bragin, Mody, et al. 2002; Bragin et al. 2007; Zijlmans et al. 2012). As the FRs 
may occur simultaneous with EEG spikes, the EEG spikes concomitant with FRs 
were termed “red spikes” and seem to be generated by seizure onset regions and the 
EEG spikes without FRs were referred as “green spikes” and usually appear in non-
epileptic brain regions (Engel et al. 2009). Consistent with this link between the “red” 
EEG spikes and FRs, both those EEG spikes (Stafstrom 2005; Bazhenov et al. 2008) 
and the FRs (Azouz et al. 1996; Jiruska and Bragin 2011) were associated with an 
enhanced depolarization phenomenon (or local paroxysmal depolarizing shift) 
supported by an enhanced persistent sodium current. Therefore, the inhibition of the 
SW discharges observed in Study 1 and 2 could be associated with the inhibitory 
effects of SCS and VNS on the FRs and their underlying persistent sodium currents. 
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In accordance with the mechanistic aspects discussed above, Study 3 indeed 
revealed that the level of FR activity was significantly correlated with the severity of 
the SW discharges, which is consistent with previous observations (Bragin et al. 
2004; Zijlmans et al. 2009; Bechstein et al. 2012; Kerber et al. 2013). Moreover, 
Study 3 showed that both SCS and VNS inhibited the FR activity in a similar 
manner and that this inhibition was proportional with the SCS and VNS frequency. 
One more interesting observation from Study 3 was that – similar with the above 
mentioned “green spikes” – ECoG spikes associated with FRs were almost absent in 
the baseline activity whereas practically all SW discharges were associated with FRs, 
i.e. comprised “red” spikes. Furthermore, this association phenomenon between SW 
discharges and FRs was clearly disrupted by SCS and VNS and in both situations 
higher frequency stimulation tended to turn more “red spikes” into “green spikes”. 
Thus, the phenomenon of association between FRs and SW discharges may reflect 
the hypersynchronized neuronal discharges during seizures (Danober et al. 1998; 
Bragin, Mody, et al. 2002; Duncan et al. 2006; Bragin et al. 2007; Bazhenov et al. 
2008; Zijlmans et al. 2012), and their dissociation a reduction of that neuronal 
hypersynchrony in response to SCS and VNS. 
As mentioned above, the FRs seem to be supported by a paroxysmal depolarizing 
shift generated by an enhanced persistent sodium current (Azouz et al. 1996; Jiruska 
and Bragin 2011). Since blocking of the persistent sodium current is an important 
mechanism of action of several AEDs (Bazhenov et al. 2008; Schulze-Bonhage 2010; 
Muñana 2013; Zaccara et al. 2015), the FRs inhibition induced by high frequency 
SCS and VNS may have supporting mechanisms similar with those AEDs and hence 
similar seizure suppressing effects. Furthermore, the results of Study 3 suggest that 
the FRs could be applied to evaluate the severity of an epileptic condition for clinical 
purposes, such as adjusting a therapeutic regime and estimating a prognosis. Since 
the HFOs can be extracted from wideband EEG recordings (Worrell et al. 2008; 
Telenczuk et al. 2011), using the FRs for such purposes in epileptic patients is 
becoming possible without invasive techniques of signal acquisition with 
microelectrodes. 
 
4.5. An integrative view of the present results 
The present thesis investigated the SW changes induced by two well-known 
neuromodulation therapies, i.e. VNS with recognized antiepileptic effects (Ben-
Menachem 2012) and SCS which is currently used for pain relief, but also with a 
possible antiepileptic potential (Ozcelik et al. 2007; Harreby et al. 2011a). In this 
respect, several stimulation frequencies have been tested to establish the most 
effective SCS and VNS frequency regarding the inhibition of seizures. In addition, 
how those SCS and VNS frequencies affected the SW-related FR activity was also 
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investigated to get an insight in the mechanisms supporting the seizure inhibition 
effects of these stimulation therapies. 
Corroborating the results of all three studies included in this work, one can see that 
both VNS and SCS attenuated the SW discharges at high frequency stimulation (see 
Study 1 and 2). As illustrated by the SCS and VNS effects on the SW-related FRs, 
the attenuation of the SW discharges was associated with an inhibition of the FR 
activity in both cases (see Study 3). Since the FR activity seems a reliable marker 
for the hypersynchronous firing of hyperexcitable neurons generating the seizures 
(Bragin, Mody, et al. 2002; Bragin et al. 2007; Zijlmans et al. 2012), the FR 
inhibition induced by SCS and VNS indicates that both methods attenuate in a 
similar manner such neuronal conditions. Although the SW discharges and the FR 
events almost always occurred simultaneously in the “no stimulation” condition, this 
simultaneity was only partial during SCS and VNS (see Study 3). Moreover, this 
dissociation between the SW discharges and the FRs appeared to be proportional 
with the SCS and VNS frequency (see Study 3). Hence, both SCS and VNS, 
especially at a high stimulation frequency, may thus turn the so called “red spikes” 
associated with seizures into “green spikes” associated with non-seizure conditions 
(see above). 
Although the inhibitory effects of SCS and VNS on the SW discharges and FRs are 
likely mediated by different mechanisms, the activation of thalamus may still play a 
key role in both methods. Whereas studies have shown that VNS activates the 
thalamus (Henry 2002) and may thereby attenuate the SW discharges and FRs, it is 
likely that the similar effects of SCS were induced by indirect thalamic stimulation 
through this procedure. 
 
4.6. Limitations and perspectives of the present work 
Although the chronic efficacy of 30 Hz VNS has been confirmed in the clinics (Ben-
Menachem 2002), the long-term anticonvulsive effects of higher stimulation 
frequencies still need to be further investigated. Meanwhile, SCS for seizure control 
is a potentially new therapy for epilepsy. Therefore, although this thesis showed that 
the acute anticonvulsive effects of SCS and VNS are similar, the long-term 
anticonvulsive effects of SCS are completely unknown. Hence, the present findings 
should be tested in chronic epilepsy animal models to better understand and confirm 
the acute VNS and SCS effects observed in this thesis. 
Since this study was designed for a preliminary screening of several SCS and VNS 
frequencies in one and same animal, the tested SCS and VNS frequencies were 
applied in each rat separated by a relatively short washout interval, i.e. 5 minutes for 
SCS and 4 minutes for VNS. Therefore, a potential interaction among the tested 
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frequencies in regard with stimulation effects cannot be ruled out. However, such an 
interaction should be limited according to the visual observation and the statistical 
analysis of the effects induced by those frequencies. Thus, the ECoG and IC signals 
recorded 30 seconds after the SCS and VNS offset did not differ from the pre-
stimulation recordings, which indicates that the seizure activity soon returned to the 
pre-stimulation level after each stimulation session. In addition, there was no 
significant difference of the frequency-dependent stimulation effects among the 
stimulation loops and across animals. Since the stimulation frequency was randomly 
arranged in each of those stimulation loops, this observation suggests that neither the 
stimulation order influenced the effects, nor any crosstalk effect was caused by the 
different stimulation frequencies from a loop. 
The current intensity of SCS and VNS was selected as the maximum current 
intensity value causing no significant side effects during stimulation at the highest 
investigated frequency. In doing so, the objective was to maximize the number of 
the recruited spinal cord or vagus nerve fibers while minimizing undesirable side 
effects. In addition, an ideal stimulation intensity in the case of an implantable 
method should also consider the power consumption, i.e. such a method should 
induce the maximum expected effects with a minimum power consumption yet 
without damaging the targeted nerves. As this study did not investigate such 
efficiency and safety aspects, the influence of the stimulation pulse intensity and 
duration on seizures should be evaluated in the future. 
To summarize, while the work demonstrated that high frequency VNS and SCS 
attenuated the morphological SW discharges and FRs rate in rats, more evidence is 
still needed as the findings in rat model do not necessarily signify it works in the 
same way in patients. In general, the thesis proposes a possibility of improving the 
electrically antiepileptic effects using two clinically available technologies and 
discreet consideration will be certainly taken for the application in patients.
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5. CONCLUSIONS 
The present thesis hypothesized that the antiepileptic effects of SCS and VNS could 
be improved by using higher stimulation frequencies than those that are currently 
used with these therapies or proposed in the literature. This was investigated in a rat 
model of epileptic seizures. 
Study 1 and 2 aimed to establish the most effective SCS and VNS frequency for 
seizure attenuation. Study 3 further explored how the tested stimulation frequencies 
influenced the FR activity associated with seizures. The results of this work 
consistently indicated that stimulation at frequencies above 100 Hz achieved better 
seizure suppression in both SCS and VNS. Furthermore, the results demonstrated 
that SCS and VNS attenuated the FR activity in a similar way and that this 
attenuation was consistently stronger at the higher frequencies. Thus, this PhD work 
indicates that high frequency SCS could be a potential electrical therapy for epilepsy 
and that VNS for seizure control may be improved by using a higher stimulation 
frequency than the presently used 30 Hz.  
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SUMMARY
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Nearly 50 million people worldwide have epilepsy and one-third of them do not 
respond well to any antiepileptic drugs. Given the large population of patients 
experiencing drug resistant epilepsy, increased attention has been paid over the 
last two decades to the development of electrical stimulation therapies as alter-
native antiepileptic treatments. In spite of these developments, the antiepilep-
tic efficacy of such electrical stimulation therapies is still relatively low. One rea-
son for not being able to increase this efficacy is the limited knowledge about 
the effect of the stimulation parameters regarding their ability to inhibit seizures. 
 
The present thesis hypothesized that the antiepileptic effects of vagus nerve stim-
ulation and spinal cord stimulation could be improved by using higher stimulation 
frequencies than those that are currently used in clinic or proposed in the literature.
